Accessibility statement
Homepage
Sitemap
Search
Contact
Print
Value through Innovation
Help
jump to main navigation
jump to content
Home
Contact
Site Map
Search
main navigation
jump to content
to meta navigation
News Centre
Corporate Profile
Corporate Responsibility
Global Activities
Research & Development
Clinical Trials
Products
Contract Manufacturing
Careers
page content
jump to main navigation
to meta navigation
Oncology and white room
No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player
Discover oncology website
Discover the white room
Our Global Activities
Our Countries A-Z
Albania
Argentina
Armenia
Austria
Australia
Azerbaijan
Bahrain
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Ethiopia
Finland
France
Georgia
Germany
Germany Headquarters
Greece
Ghana
Hong Kong
Hungary
India
Indonesia
Iraq
Irland
Israel
Italy
Japan
Jordan
Kazakhstan
Kenya
Kirghizia
Kuweit
Latvia
Lebanon
Libya
Lithuania
Macedonia
Malawi
Malaysia
Malta
Mauritius
Mexico
Moldavia
Mongolia
Montenegro
The Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Peru
The Philippines
Poland
Portugal
Quatar
Romania
Russia
Saudi Arabia
Seychelles
Serbia
Singapore
Slovakia
Slovenia
Somalia
South Africa
South Korea
Spain
Sudan
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Turkey
Turkmenistan
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Venezuela
Vietnam
Yemen
for US residents
Latest Press Releases
03.02.2012
Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration
31.01.2012
FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes
-
For Non-U.S. and Non-UK Media
26.01.2012
Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
26.01.2012
Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*
-
FOR NON-US MEDIA ONLY
14.12.2011
Boehringer Ingelheim significantly expands its supply center for China
Further press releases
Partnership with Ashoka
Ashoka/Changemakers
Drug discovery process
See further details
Diabetes Initiative
More about the initiative
back to top
Further Media Channels
Mobile Devices
RSS Feed
Follow us on Facebook
Follow us on Twitter
Follow us on YouTube
Follow us on flickr
Top Links
Take-away-info
Annual report
Financial highlights
Licensing & Partnering
Careers - experienced
Indication areas
Stroke Prevention
Consumer Health Care
Biopharmaceuticals
Animal Health
Research Areas
Contact